These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12722550)

  • 21. Polymorphisms of beta-adrenergic receptors in heart failure.
    Liggett SB
    Am J Med; 2004 Oct; 117(7):525-7. PubMed ID: 15464712
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L; Taylor MR
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrative genomics strategy for systematic characterization of genetic loci modulating phenotypes.
    Bao L; Peirce JL; Zhou M; Li H; Goldowitz D; Williams RW; Lu L; Cui Y
    Hum Mol Genet; 2007 Jun; 16(11):1381-90. PubMed ID: 17428815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms and oxidative stress in heart failure.
    Alameddine FM; Zafari AM
    Congest Heart Fail; 2002; 8(3):157-64, 172. PubMed ID: 12045384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure.
    Kittleson MM; Minhas KM; Irizarry RA; Ye SQ; Edness G; Breton E; Conte JV; Tomaselli G; Garcia JG; Hare JM
    Physiol Genomics; 2005 May; 21(3):299-307. PubMed ID: 15769906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrative approach for the identification of quantitative trait loci.
    Arbilly M; Pisanté A; Devor M; Darvasi A
    Anim Genet; 2006 Aug; 37 Suppl 1():7-9. PubMed ID: 16886995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration--a key to success in the genetic dissection of complex diseases?
    Yagil Y; Yagil C
    Trends Cardiovasc Med; 2006 Feb; 16(2):35-8. PubMed ID: 16473759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetics of chronic heart failure--beta blockers].
    Vasků A; Spinarová L; Pávková-Goldbergová M; Spinar J; Soucek M; Vítovec J
    Cas Lek Cesk; 2006; 145(2):148-52; discussion 152-3. PubMed ID: 16521406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
    Shin J; Lobmeyer MT; Gong Y; Zineh I; Langaee TY; Yarandi H; Schofield RS; Aranda JM; Hill JA; Pauly DF; Johnson JA
    Am J Cardiol; 2007 Jan; 99(2):250-5. PubMed ID: 17223428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifier genes and sickle cell anemia.
    Steinberg MH; Adewoye AH
    Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human obesity gene map: the 2004 update.
    Pérusse L; Rankinen T; Zuberi A; Chagnon YC; Weisnagel SJ; Argyropoulos G; Walts B; Snyder EE; Bouchard C
    Obes Res; 2005 Mar; 13(3):381-490. PubMed ID: 15833932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.